Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire
- 3 October 2011
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 14 (8) , 1109-1116
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Procter & Gamble
- Gilead Life Sciences
- Hayward Medical Communications/Shire Pharmaceuticals
This publication has 36 references indexed in Scilit:
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapyJournal of Bone and Mineral Research, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 TrialJournal of Bone and Mineral Research, 2009
- Preferences of patients receiving bisphosphonates – How to influence the therapeutic adherenceBiomedicine & Pharmacotherapy, 2008
- Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for OsteoporosisMayo Clinic Proceedings, 2007
- The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonatesCurrent Medical Research and Opinion, 2007
- Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims DatabasesMayo Clinic Proceedings, 2006
- Adherence, patient preference and dosing frequency: Understanding the relationshipBone, 2006
- Epidemiology of OsteoporosisOsteoporosis International, 1999
- Perspective how many women have osteoporosis?Journal of Bone and Mineral Research, 1992